Timothy Craig
Overview
Explore the profile of Timothy Craig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
2484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sarkar A, Nwagwu C, Craig T
Med Clin North Am
. 2024 May;
108(4):747-755.
PMID: 38816115
Hereditary angioedema is a rare autosomal dominant condition characterized by episodes of swelling of the upper airway, intestines, and skin. The disorder is characterized by deficiency in C1 esterase inhibitor...
12.
Reshef A, Buttgereit T, Betschel S, Caballero T, Farkas H, Grumach A, et al.
J Allergy Clin Immunol
. 2024 Apr;
154(2):398-411.e1.
PMID: 38670233
Background: Angioedema (AE) manifests with intermittent, localized, self-limiting swelling of the subcutaneous and/or submucosal tissue. AE is heterogeneous, can be hereditary or acquired, may occur only once or be recurrent,...
13.
Papadopoulos N, Custovic A, Deschildre A, Gern J, Nieto Garcia A, Miligkos M, et al.
Pediatr Allergy Immunol
. 2024 Apr;
35(4):e14129.
PMID: 38664926
Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and...
14.
Petersen R, Fijen L, Apfelbacher C, Magerl M, Weller K, Aberer W, et al.
J Allergy Clin Immunol Pract
. 2024 Apr;
12(6):1614-1621.
PMID: 38609017
Background: Clinical trials investigating drugs for the acute treatment of hereditary angioedema attacks have assessed many different outcomes. This heterogeneity limits the comparability of trial results and may lead to...
15.
Craig T, Richwine K, Ishmael F
Ann Allergy Asthma Immunol
. 2024 Feb;
132(6):723-729.e4.
PMID: 38412917
Background: Hereditary angioedema (HAE) is an autosomal dominant disease with variable expression. In some families with identical genetic abnormalities, the expression can range from several attacks per month to no...
16.
Rubeiz C, Asero R, Betschel S, Craig T, Grumach A, Hide M, et al.
World Allergy Organ J
. 2024 Jan;
17(1):100858.
PMID: 38235261
Background: Chronic spontaneous urticaria (CSU) is a common condition treated by allergist/immunologists, but the only FDA-approved biologic medication, omalizumab, may be underutilized globally. Objective: This study was performed to determine...
17.
Kiani-Alikhan S, Gower R, Craig T, Wedner H, Kinaciyan T, Aygoren-Pursun E, et al.
J Allergy Clin Immunol Pract
. 2023 Dec;
12(3):733-743.e10.
PMID: 38122865
Background: Berotralstat is a first-line, once-daily oral plasma kallikrein inhibitor approved for prophylaxis of hereditary angioedema (HAE) attacks in patients 12 years or older. Objective: This analysis examined the safety...
18.
Lumry W, Craig T, Anderson J, Riedl M, Li H, Tachdjian R, et al.
Allergy Asthma Clin Immunol
. 2023 Dec;
19(1):105.
PMID: 38082409
Background: Real-world data on subcutaneous C1INH (C1INH[SC]) usage and patient-level impacts on hereditary angioedema (HAE)-related outcomes and quality of life (QoL) are both lacking and challenging to generate using conventional...
19.
Baptist A, Freigeh G, Nelson B, Carpenter L, Arora N, Wettenstein R, et al.
Ann Allergy Asthma Immunol
. 2023 Oct;
132(1):76-81.e2.
PMID: 37852604
Background: Hereditary angioedema (HAE) is a rare condition characterized by potentially fatal, recurrent episodes of painful swelling. Whereas there are limited studies evaluating the quality of life of individuals with...
20.
Duong-Quy S, Chirakalwasan N, Nguyen-Nhu V, Craig T
Front Neurol
. 2023 Sep;
14:1264665.
PMID: 37662049
No abstract available.